Literature DB >> 986052

Sites of action of morphine involved in the development of physical dependence in rats. II. Morphine withdrawal precipitated by application of morphine antagonists into restricted parts of the ventricular system and by microinjection into various brain areas.

E Laschka, H Teschemacher, P Mehraein, A Herz.   

Abstract

Morphine withdrawal was precipitated by injection of various morphine antagonists into restricted parts of the ventricular system or by microinjection of levallorphan into specific brain areas of rats made dependent on morphine by repeated pellet implantation. When the antagonists could spread only within the lateral ventricles and the 3rd ventricle, a weak withdrawal syndrome was induced; by antagonist administration into the restricted 4th ventricle, however, strong withdrawal signs like jumping were elicited even at small dosages. In microinjection experiments, structures in the midbrain and the lower brain stem proved to be the most sensitive to antagonist action. Although microinjections into thalamic nuclei also had some effect, it could not be excluded that the effects were due to uncontrolled spreading of the drug. This became especially clear from experiments with tritium-labeled levallorphan. It is concluded that brain structures located in the anterior parts of the floor of the 4th ventricle and/or caudal parts of the periaqueductal gray matter are important sites of action for the development of physical dependence on morphine.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 986052     DOI: 10.1007/bf00421383

Source DB:  PubMed          Journal:  Psychopharmacologia


  29 in total

1.  Site of naloxone-precipitated opiate withdrawal dissociates from that at which apomorphine reinitiates this phenomenon.

Authors:  R Schulz; J Bläsig; E Laschka; A Herz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1978-10       Impact factor: 3.000

2.  Attenuation of the morphine withdrawal syndrome by inhibition of catabolism of endogenous enkephalins in the periaqueductal gray matter.

Authors:  R Maldonado; M C Fournié-Zaluski; B P Roques
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-04       Impact factor: 3.000

3.  Chronic morphine treatment modulates the extracellular levels of endogenous enkephalins in rat brain structures involved in opiate dependence: a microdialysis study.

Authors:  Magdalena Mas Nieto; Jodie Wilson; Annie Cupo; Bernard P Roques; Florence Noble
Journal:  J Neurosci       Date:  2002-02-01       Impact factor: 6.167

4.  Intracerebral injection of different antibodies against endogenous opioids suggests alpha-neoendorphin participation in control of feeding behaviour.

Authors:  R Schulz; A Wilhelm; G Dirlich
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-06       Impact factor: 3.000

5.  Generalization tests with intraventricularly applied pro-enkephalin B-derived peptides in rats trained to discriminate the opioid kappa receptor agonist ethylketocyclazocine.

Authors:  G T Shearman; R Schulz; P W Schiller; A Herz
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

6.  Differential desensitization of mu- and delta- opioid receptors in selected neural pathways following chronic morphine treatment.

Authors:  F Noble; B M Cox
Journal:  Br J Pharmacol       Date:  1996-01       Impact factor: 8.739

7.  Sites of action of morphine involved in the development of physical dependence in rats. III. Autoradiographic studies.

Authors:  E Laschka; A Herz
Journal:  Psychopharmacology (Berl)       Date:  1977-06-06       Impact factor: 4.530

8.  Ethanol and tetrahydroisoquinoline alkaloids do not produce narcotic discriminative stimulus effects.

Authors:  G T Shearman; A Herz
Journal:  Psychopharmacology (Berl)       Date:  1983       Impact factor: 4.530

9.  Regional cerebral glucose utilization in withdrawal following systemic and intracerebroventricular sufentanil administration.

Authors:  R E Adams; G F Wooten
Journal:  Neurochem Res       Date:  1994-10       Impact factor: 3.996

10.  Regional Fos expression induced by morphine withdrawal in the 7-day-old rat.

Authors:  Anika A McPhie; Gordon A Barr
Journal:  Dev Psychobiol       Date:  2009-11       Impact factor: 3.038

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.